Impact of postoperative duration of Aspirin use on longevity of bioprosthetic pulmonary valve in patients who underwent congenital heart disease repair

• Egile Nagusiak: Tae-Woong Hwang (Egilea), Sung-Ook Kim (Egilea), Sang-Yun Lee (Egilea), Seong-Ho Kim (Egilea), Eun-Young Choi (Egilea), So-Ick Jang (Egilea), Su-Jin Park (Egilea), Hye-Won Kwon (Egilea), Hyo-Bin Lim (Egilea), Chang-Ha Lee (Egilea), Eun-Seok Choi (Egilea)
• Formatua: Liburua
• Argitaratua: Korean Pediatric Society, 2016-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

PurposeGenerally, aspirin is used as a protective agent against thrombogenic phenomenon after pulmonary valve replacement (PVR) using a bioprosthetic valve. However, the appropriate duration of aspirin use is unclear. We analyzed the impact of postoperative duration of aspirin use on the longevity o...